Investigation of Preservative-Free Ophthalmic Solution in Ocular Dryness
NCT05778942 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2024-02-06
Summary
This is a multicenter, prospective, observational, open-label, non-interventional study evaluating the clinical performance and the safety of 4 daily instillations of the ophthalmic solution in the treatment of eye discomfort, in particular due to eye dryness
Conditions
- Dry Eye Syndromes
Interventions
- DEVICE
-
Eyestil SYNFO
Instillation of study drug in both eyes: preservative-free ophthalmic solution based on sodium hyaluronate and xanthan gum
Sponsors & Collaborators
-
SIFI SpA
lead INDUSTRY
Principal Investigators
-
Claudine Civiale · SIFI S.p.A.
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-02-23
- Primary Completion
- 2023-11-06
- Completion
- 2023-12-19
Countries
- Spain
Study Locations
More Related Trials
-
Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects
NCT03524157 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Efficacy and Tolerability of SYSTANE Complete in Patients With Dry Eye Disease
NCT03492541 ·Status: COMPLETED ·Phase: NA
-
Comprehensive Study on Dry Eye and Ocular Surface Disease Prior and After Cataract Surgery
NCT04711642 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
NCT00938704 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Evaluation of Systane® Gel Drops in Dry Eye Subjects
NCT02380248 ·Status: COMPLETED ·Phase: NA
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
NCT04393441 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)
NCT03223909 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating Impact of Systane iLux on Dryness Symptoms and Wearing Time in Contact Lens Users
NCT05306561 ·Status: RECRUITING ·Phase: NA
-
Autologous Serum Efficacy Study in Patients With Severe Dry Eye
NCT00779987 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry Eye
NCT02420730 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry Eye
NCT01959854 ·Status: COMPLETED ·Phase: NA
-
Study on Prevention and Treatment of Dry Eye in Patients Using Glaucoma Drops
NCT03515187 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparison of Systane Free vs. Saline in the Treatment of Dry Eye
NCT00388791 ·Status: COMPLETED ·Phase: PHASE4
-
Late Phase II Confirmatory Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01189032 ·Status: COMPLETED ·Phase: PHASE2
-
Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry Eye
NCT03617315 ·Status: COMPLETED ·Phase: NA
-
A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye Patients
NCT01468168 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.
NCT04704531 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
A Multi-Center Study Subjects With Dry Eye Syndrome
NCT01745887 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye
NCT01558999 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye
NCT02446015 ·Status: COMPLETED ·Phase: NA
-
PMCF Study to Evaluate Performance and Safety of "Hyaluronic Acid (HA)-Based Eyedrops" Used to Relieve Dry Eye Symptoms
NCT05807360 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy Study of DE-110 Ophthalmic Suspension for the Treatment of Dry Eye Disease
NCT01239069 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Safety and Efficacy of AVX-012 in Subjects With Mild-to-moderate Dry Eye Syndrome
NCT03162094 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2